Top Markets
#1 Threshold Network Threshold Network +50.29%
#2 TENDIES TENDIES +46.06%
#3 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#4 Kinetiq Kinetiq +16.51%
#5 OSK OSK +16.24%
#6 Mubarak Mubarak +14.83%
#7 Ape and Pepe Ape and Pepe +12.62%
#8 Maple Finance Maple Finance +12.32%
#9 MultiversX MultiversX +11.97%
#10 Kite Kite +11.48%
Coin of the day
Threshold Network Threshold Network
Setări
Limbă
ROMâNă
Monedă
USD
Temă
Neumora Therapeutics, Inc. Common Stock Neumora Therapeutics, Inc. Common Stock

Neumora Therapeutics, Inc. Common Stock

NMRA
Rang în acțiuni #17160
Neumora Therapeutics, Inc. is a specialized biopharmaceutical company... Neumora Therapeutics, Inc. is a specialized biopharmaceutical company progressing through clinical trials, dedicated to advancing therapies for a range of neurological, psychiatric, and neurodegenerative conditions. Its most advanced candidate, navacaprant (also known as NMRA-140), is a novel, once-daily oral kappa opioid receptor antagonist currently undergoing Phase 3 clinical trials for the management of major depressive disorder. Additionally, NMRA-511 is in Phase 1 studies, targeting agitation experienced by individuals with Alzheimer's-related dementia. Another compound, NMRA-266, is also in Phase 1 clinical development, aimed at addressing schizophrenia and other related neuropsychiatric conditions. Beyond its clinical programs, Neumora maintains a preclinical pipeline featuring several promising candidates: NMRA-NMDA for schizophrenia, NMRA-CK1d (a CK1d inhibitor initiative) for amyotrophic lateral sclerosis (ALS), NMRA-NLRP3 for specific neurodegenerative ailments, and NMRA-GCase for Parkinson's disease. Tracing its origins to a 2019 incorporation, the company, initially known as RBNC Therapeutics, Inc., adopted its current name, Neumora Therapeutics, Inc., in October 2021. Its corporate headquarters are situated in Watertown, Massachusetts.
Preț acțiune
$1.37
Capitalizare de piață
$254.58M
Schimbare (1 zi)
3.31%
Schimbare (1 an)
-21.03%
Țară
US
Tranzacționează Neumora Therapeutics, Inc. Common Stock (NMRA)

Categorie

Healthcare
Câștiguri pentru Neumora Therapeutics, Inc. Common Stock (NMRA)
Câștiguri în 2026 TTM: 0
Conform celor mai recente rapoarte financiare ale Neumora Therapeutics, Inc. Common Stock, câștigurile actuale ale companiei sunt 0. În anul 2026, compania a înregistrat un câștig de 0, egal cu câștigului din 2026, care a fost de 0. Câștigurile afișate pe această pagină sunt cele înainte de dobânzi și impozite, cunoscute și ca EBIT.
Istoricul câștigurilor pentru Neumora Therapeutics, Inc. Common Stock din 2026 până în 2026
Câștiguri la sfârșitul fiecărui an
An Câștiguri Schimbă
Nu sunt suficiente date pentru perioada selectată.
Câștiguri pentru companii similare sau concurente
Companie Câștiguri Diferență de câștiguri Țara
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
$-3.09B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
$-4.02B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH